-
-
-
-
-
-
-
AstraZeneca launches direct-to-consumer platform to expand access to medications for US patients, including those living with chronic conditions
-
-
-
-
-
-
-
US Food and Drug Administration accepts for review AstraZeneca’s Supplemental Biologics License Application for self-administration of FLUMIST® QUADRIVALENT (Influenza Vaccine Live, Intranasal)
-
-
-
-
-
-
-
PT027 Recommended by FDA Advisory Committee as New Rescue Treatment for Asthma
-
-
-
-
-
-
-
FibroGen (FGEN) Says FDA Advisory Committee Voted to Recommend Not Approving Roxadustat
-
-
-
-
-
-
-
Covid-19 vaccines: Efficacy results likely in November - Morgan Stanley
-
-
-
-
-
-
-
AstraZeneca (AZN), Merck (MRK) Announce LYNPARZA Recommended by FDA Advisory Committee for First-Line Maintenance Therapy in Germline BRCA-Mutated Metastatic Pancreatic Cancer
-
-
-
-
-
-
-
AstraZeneca (AZN) Terminates Valeant's (VRX) Brodalumab Development Agreement for Europe
-
15,627 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

